DOES THE THROMBIN GENERATION TEST PERFORMED DURING THE PHARMACOKINETIC PROFILE OF THE SUBSTITUTIVE FACTOR VIII BRING BENEFITS TO THE PERSONALIZED TREATMENT OF PEDIATRIC PATIENTS AND ADULT HEMOPHILIA A PATIENTS UNDER PROPHYLAXIS ?: